WS #10669

From 500 msgs · 7 key-dev

Merck KGaA to acquire Bio-Techne at $73/share in cash, EV $11.3B; deal expected to be immediately accretive to sales and EBITDA.

Merck KGaA acquires Bio-Techne for $11.3B

Merck KGaA to acquire Bio-Techne at $73/share in cash, EV $11.3B; deal expected to be immediately accretive to sales and EBITDA.

Full world state #10669 →